These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24016317)

  • 61. The feasibility and safety of S-adenosyl-L-methionine (SAMe) for the treatment of neuropsychiatric symptoms in 22q11.2 deletion syndrome: a double-blind placebo-controlled trial.
    Green T; Steingart L; Frisch A; Zarchi O; Weizman A; Gothelf D
    J Neural Transm (Vienna); 2012 Nov; 119(11):1417-23. PubMed ID: 22678699
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neurocognitive profile in psychotic versus nonpsychotic individuals with 22q11.2 deletion syndrome.
    Weinberger R; Yi J; Calkins M; Guri Y; McDonald-McGinn DM; Emanuel BS; Zackai EH; Ruparel K; Carmel M; Michaelovsky E; Weizman A; Gur RC; Gur RE; Gothelf D
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1610-8. PubMed ID: 27524298
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Youth mental health services in Italy: An achievable dream?
    Masillo A; Brandizzi M; Nelson B; Lo Cascio N; Saba R; Lindau JF; Telesforo L; Montanaro D; D'Alema M; Girardi P; McGorry P; Fiori Nastro P
    Early Interv Psychiatry; 2018 Jun; 12(3):433-443. PubMed ID: 27061589
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
    Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
    Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Emergent, remitted and persistent psychosis-spectrum symptoms in 22q11.2 deletion syndrome.
    Tang SX; Moore TM; Calkins ME; Yi JJ; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    Transl Psychiatry; 2017 Jul; 7(7):e1180. PubMed ID: 28742080
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The psychosis prodrome in adolescent patients viewed through the lens of DSM-IV.
    Meyer SE; Bearden CE; Lux SR; Gordon JL; Johnson JK; O'Brien MP; Niendam TA; Loewy RL; Ventura J; Cannon TD
    J Child Adolesc Psychopharmacol; 2005 Jun; 15(3):434-51. PubMed ID: 16092909
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Spectrum of neuropsychiatric features associated with velocardiofacial syndrome (Deletion 22q11.2)].
    Sieberer M; Runte I; Wilkening A; Pabst B; Ziegenbein M; Haltenhof H
    Fortschr Neurol Psychiatr; 2006 May; 74(5):263-74. PubMed ID: 16758538
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Psychotic symptoms influence the development of anterior cingulate BOLD variability in 22q11.2 deletion syndrome.
    Zöller D; Padula MC; Sandini C; Schneider M; Scariati E; Van De Ville D; Schaer M; Eliez S
    Schizophr Res; 2018 Mar; 193():319-328. PubMed ID: 28803847
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Psychiatric comorbidity in autism spectrum disorder: Correspondence between mental health clinician report and structured parent interview.
    Stadnick N; Chlebowski C; Baker-Ericzén M; Dyson M; Garland A; Brookman-Frazee L
    Autism; 2017 Oct; 21(7):841-851. PubMed ID: 27407039
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome: a 3-year follow-up study.
    Antshel KM; Shprintzen R; Fremont W; Higgins AM; Faraone SV; Kates WR
    J Am Acad Child Adolesc Psychiatry; 2010 Apr; 49(4):333-44. PubMed ID: 20410726
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis.
    Fusar-Poli P; Nelson B; Valmaggia L; Yung AR; McGuire PK
    Schizophr Bull; 2014 Jan; 40(1):120-31. PubMed ID: 23180756
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reading problems, psychiatric disorders, and functional impairment from mid- to late adolescence.
    Goldston DB; Walsh A; Mayfield Arnold E; Reboussin B; Sergent Daniel S; Erkanli A; Nutter D; Hickman E; Palmes G; Snider E; Wood FB
    J Am Acad Child Adolesc Psychiatry; 2007 Jan; 46(1):25-32. PubMed ID: 17195726
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multivariate patterns of disrupted sleep longitudinally predict affective vulnerability to psychosis in 22q11.2 Deletion Syndrome.
    Reich N; Delavari F; Schneider M; Thillainathan N; Eliez S; Sandini C
    Psychiatry Res; 2023 Jul; 325():115230. PubMed ID: 37201254
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Longitudinal study of cerebral surface morphology in youth with 22q11.2 deletion syndrome, and association with positive symptoms of psychosis.
    Radoeva PD; Bansal R; Antshel KM; Fremont W; Peterson BS; Kates WR
    J Child Psychol Psychiatry; 2017 Mar; 58(3):305-314. PubMed ID: 27786353
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Longitudinal Psychiatric and Developmental Outcomes in 22q11.2 Deletion Syndrome: A Systematic Review.
    Jhawar N; Brown MJ; Cutler-Landsman D; Kates WR; Angkustsiri K; Antshel KM
    J Dev Behav Pediatr; 2021 Jun-Jul 01; 42(5):415-427. PubMed ID: 34110308
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Psychopathological characteristics in ultra-high risk for psychosis with and without comorbid ADHD.
    Ribolsi M; Prosperi Porta D; Sacco R; Di Lorenzo G; Fiori Nastro F; Albergo G; Di Lazzaro V; Costa A
    Early Interv Psychiatry; 2024 Jul; 18(7):578-582. PubMed ID: 38690753
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevalence of psychotic and non-psychotic disorders in relatives of patients with a first episode psychosis.
    Faridi K; Pawliuk N; King S; Joober R; Malla AK
    Schizophr Res; 2009 Oct; 114(1-3):57-63. PubMed ID: 19666214
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries.
    Salokangas RK; Ruhrmann S; von Reventlow HG; Heinimaa M; Svirskis T; From T; Luutonen S; Juckel G; Linszen D; Dingemans P; Birchwood M; Patterson P; Schultze-Lutter F; Klosterkötter J;
    Schizophr Res; 2012 Jul; 138(2-3):192-7. PubMed ID: 22464922
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prevalence of ADHD in children with velocardiofacial syndrome: a preliminary report.
    Zagursky K; Weller RA; Jessani N; Abbas J; Weller EB
    Curr Psychiatry Rep; 2006 Apr; 8(2):102-7. PubMed ID: 16539884
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning.
    Armando M; Girardi P; Vicari S; Menghini D; Digilio MC; Pontillo M; Saba R; Mazzone L; Lin A; Klier CM; Schäfer MR; Amminger GP
    Schizophr Res; 2012 Aug; 139(1-3):151-6. PubMed ID: 22627123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.